News about "diabetes "

Novo Nordisk Submits Updated Proposal to Acquire Metsera in Multi-Billion-Dollar Deal

Novo Nordisk Submits Updated Proposal to Acquire Metsera in Multi-Billion-Dollar Deal

Novo Nordisk has confirmed that it has submitted an updated, unsolicited proposal to acquire Metsera, which has been declared superior by Metsera’s board of directors.

Diabetes | 06/11/2025 | By Dineshwori 110

Novo Nordisk Reports 18% H1 Sales Growth, Lowers H2 Outlook for Wegovy and Ozempic

Novo Nordisk Reports 18% H1 Sales Growth, Lowers H2 Outlook for Wegovy and Ozempic

Novo Nordisk has announced its financial results for the first half of 2025, ending June 30, with sales rising 18 percent at constant exchange rates (CER) to DKK 154.9 billion (USD 24.78 billion).

Diabetes | 06/08/2025 | By Dineshwori 1256

Novo Nordisk Partners with Fangzhou to Transform Diabetes and Obesity Management

Novo Nordisk Partners with Fangzhou to Transform Diabetes and Obesity Management

Novo Nordisk and Fangzhou have signed a Memorandum of Understanding (MoU) to collaborate on the management of serious chronic conditions, including diabetes and obesity. <br />

Diabetes | 22/07/2025 | By Dineshwori 299

Boehringer Ingelheim Names Brian Hilberdink as President-US Human Pharma

Boehringer Ingelheim Names Brian Hilberdink as President-US Human Pharma

Hilberdink will play a pivotal role in fostering Boehringer's culture and driving meaningful impact for patients.

Diabetes | 21/02/2025 | By Aishwarya 260

Kadimastem Shareholders Approve Merger with NLS Pharmaceutics

Kadimastem Shareholders Approve Merger with NLS Pharmaceutics

The merger brings NLS and Kadimastem one step closer to creating a combined Nasdaq-traded biotechnology company with a robust portfolio of advanced therapies for neurodegenerative diseases and diabetes.

Diabetes | 01/02/2025 | By Abha 224

Eris Lifesciences Announces Acquisition of Biocon Biologics

Eris Lifesciences Announces Acquisition of Biocon Biologics

Eris Lifesciences Ltd. has recently acquired Biocon Biologics’ Branded Formulations business in India in a deal worth INR 1,242 crore.

Diabetes | 19/03/2024 | By Manvi 470


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members